chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine 1-23-15 - In evening felt lethargic - slept 11 hours / achy for 24 hours 6 days later 1-28-15 blotchy rash on stomach, legs, arms, neck, and back of hands.
On June 4, 1999 was vaccinated with one dose of varicella virus, On June 12, 1999 the pt developed varicella with approximately 300 non-localized lesions. The pt was afebrile.
pt brought to hospital; wife states pt is "not himself"; confusion and unable to follow commands; not normal for him; was supposed to go to dialysis but noticed clot in fistula; states has a recent positive test for COVID; COVID test is positive; vascular services addressed fistula; during hospitalization pt was found pulseless and unresponsive; intubated and several rounds of CPR; never regained circulation; pt died in the hospital
Tongue and throat swelling about 30 minutes after receiving vaccine. Took Claritin about 15 minutes after onset of symptoms. Symptoms mostly subsided about 1 hour after taking Claritin. Slight throat swelling and difficulty swallowing until a dose of Benadryl was taken the following day.
Background:41-year-old male reported that he awakened with right lower leg pain intermittently since  approx. May 10 2021. Woke on June 10 with increased pain and swelling to RLE.  He tried to "run it out" but the pain worsened. In the ER he was noted to have elevated D-Dimer- 1980, ESR of 27, labs otherwise normal. Ultrasound showed DVT. He was started on hydrocodone-APAP and Xarelto.   Returned on 11 June with SOB. PE was confirmed. Admitted to ICU   Note today states continued swelling and pain to RLE. Considering transfer to hospital for vascular consultation and further management.
A nurse reported that a pt received Typhoid Vaccine, USP, Heat Phenol Inactivated and within 1 to 2 days, post vax, developed fever and an injection site reaction characterized by a tender and swollen arm. The pt was prescribed an oral antibiotic. No further information was available at the date of this report. The reporter indicated that 3 pts experienced this event; however, they are not presently identifiable. Additional reports will be generated when indentifying information is provided.
Around 07:15AM ET  on 0/04/2023 I woke up with a dry throat and made tea to help but my throat become so sore I went to urgent care around 2PM ET that afternoon it felt like needle in my throat and my neck under my jaw began to hurt and it was throbbing . I had no fatigue or other symptoms just the pain.  At Urgent Care a Strep and COVID-19 tests were performed both tests were negative. At an inspection of my throat I was diagnosed with tonsillitis.
PAIN, HARD AREA AT INJECTION SITE, REDNESS AT AND SURROUNDING INJECTION SITE.
Random outbursts of extreme itchiness and burning sensation all throughout body and redness on face, arms and legs. Has occurred at least once a week after getting vaccine. Almost like hives- lasts for about an hour sometimes longer, will linger than reside after awhile and happen again few days later
feels very weak; shaking; can't eat; strong metal taste , like she was "chewing on stainless steel"; bothered by smell"; the inside of her mouth was covered with blisters; increased heart rate; worse flu she could have"; terrible headache; fever; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel") and PAROSMIA (bothered by smell") in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus, Allergic reaction to analgesics (Allergies include codeine and sulfa drugs.) and Sulfonamide allergy. Concomitant products included ISOPHANE INSULIN (NPH INSULIN) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting). At the time of the report, ASTHENIA (feels very weak), TREMOR (shaking), DECREASED APPETITE (can't eat), DYSGEUSIA (strong metal taste , like she was "chewing on stainless steel"), PAROSMIA (bothered by smell"), MOUTH ULCERATION (the inside of her mouth was covered with blisters), HEART RATE INCREASED (increased heart rate), INFLUENZA LIKE ILLNESS (worse flu she could have"), HEADACHE (terrible headache), PYREXIA (fever) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
This is in follow-up to report(s) previously submitted on 1/16/2007. Initial and follow-up information has been received from a physician through the Merck pregnancy registry concerning a 17 year old female with episodic reflux and dyspepsia and no known drug allergies and no previous pregnancies who on 16-Oct-2006 was vaccinated intramuscularly with the first dose of GARDASIL (0.5 ml) (lot # 653735/0688F). Concomitant therapy included PRILOSEC OTC and prenatal vitamins. From 20-Oct-2006 to 26-Oct-2006 the patient was placed on therapy with FLAGYL 500 mg twice daily for bacterial vaginitis. On 31-Oct-2006 the patient was found to have a positive pregnancy test. LMP was 11-Sep-2006. Unspecified medical attention was sought and the patient was placed on prenatal vitamins. On 19-Dec-2006, an ultrasound revealed gestational age 24.7 weeks which was not consistent with the estimated date of last menstrual period (LMP). On an unspecified date a Cystic Fibrosis carrier screen was performed, results were negative. On 22-MAR-2007 she delivered a normal, healthy male baby weighing 6 pounds 3 ounces and 18 1/2" long, with a head circumference of 33.5 cm, and APGAR scores of 9 at one and five minutes. The patient's labor and delivery was uncomplicated. No other symptoms were noted. At the time of this report, the outcome of the events was unknown. Additional information has been requested.
Noticed redness and swelling at site of injections on right thigh 4 hours after injection.
Episode of being unresponsive and dazed that lasted several minutes. Thought to be a seizure. Subsequent EEG normal.
Severe cold/flu like symptoms starting 27 hours after the first dose and lasting multiple days after.  Runny nose headache body aches lethargy and sore throat
Severe muscle aches, severe headache, fever high as 100.8, chills , severe diarrhea. complete loss of appetite, fatigue weakness
14 month presented 7/22/03 c/o rash on face and trunk x 2 wks per mother's account. Pt was seen 7/1/03 for well child visit-she received MMR and varicella vaccines-approx one week post vaccine she developed cough, runny nose, low grade temp then rash.
Pt recvd Engerix-B & 2 days following vax exp gassy, hyperperistalsis & gallbladder sx (difficulty eating fried foods); 17JUL92 also exp flu-like sx, chills, fever 102, arthralgia;
Diarrhea, severe cramping, lighter stools, 24 hours duration, improved after loperamide
Developed a blister like lesion at the site of injection/It was a clear fluid filled lesion just below the skin; This is a spontaneous report received from contactable reporter(s) (Pharmacist) from a sales representative.  A 12 year-old male patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, 30 ug single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (first dose,3 0mcg dose), for COVID-19 immunization. The following information was reported: VACCINATION SITE VESICLES (non-serious) with onset 2021, outcome "not recovered", described as "Developed a blister like lesion at the site of injection/It was a clear fluid filled lesion just below the skin". Additional information: Patient is a 12year old boy who received 2 30mcg doses of the Vaccine. One day after the 2nd dose he developed a blister like lesion at the site of injection. It was a clear fluid filled lesion just below the skin. It has persisted for 5 days although on day 5 the fluid drained from the "blister".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain; On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain) and ARTHRALGIA (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain) and ARTHRALGIA (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain). At the time of the report, PAIN IN EXTREMITY (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain) and ARTHRALGIA (On the beginning of covid he got 3 to 4 vaccine of moderna vaccine he got on both arms he started to feel pain from both arms and then they both started hurting to an extent of fingers and wrist pain to this day he has pain) had not resolved.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was provided.   This case was linked to MOD-2023-727742 (Patient Link).
2x3 area of redness at injection site.  Area hot and tender to touch.  Assessed by provider and advise to contact PH, as per voicemail left on imms. line.  Patient feels its MMR site, not varicella.  Ice as needed, advised.  Patient contacted 05/13/2005 at 1440 hours, no further progress.
30 minutes after getting the vaccine I started having trouble breathing, it lasted for about 24 hours, I used my inhaler which mildly helped. I was concerned about getting the second shot because of that reaction so I contacted my doctor probably a week after getting my first dose. He said it was a reaction to the vaccine and he said to continue taking my regular medication and I used my inhaler a little bit more than the usual for about a month. The second dose wasn't as bad, and they gave me Benadryl which helped eliminate some of those reactions. I am still using my inhaler more than I used to but not as much as that month.
pt was vaxed 4APR92; seen in office 14APR- dx Bell's Palsy seventh nerve paralysis confirmed by neurologist; no treatment initiated; pt recovering @ time of report; 24APR; had cold sx 1 wk prior to immun;
Mother brought child in for fussiness x24h on 4/21/14. Patient developed "rash" on trunk and low grade fever. My exam revealed both and typical varicella (vesicles) mild rash approximately 20 vesicles on front and back.
got the new one, got shingles/Suspected Vaccination Failure; it went into shingles; slight infection; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received first one years ago.).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the new one, got shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: it went into shingles) and infection (Verbatim: slight infection). The outcome of the vaccination failure, shingles and infection were not reported.   It was not reported if the reporter considered the vaccination failure, shingles and infection to be related to Shingles vaccine and Shingles vaccine.     It was not reported if the company considered the vaccination failure, shingles and infection to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt date: 28-Feb-2023. This case was reported by a consumer via interactive digital media. The patient had the first dose one years ago. Got the new one last winter. The doctor gave patient a medication for a slight infection and it went into shingles. The reporter stated that what he/she was saying was no matter what protection you have you could still get it. This case was considered as suspected vaccination failure since the details regarding the  time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
breakthrough covid +, asymptomatic, possible false + as repeat test negative, hospitalization unrelated
Nausea, vomiting, diarrhea, severe muscle aches and headache.
wheezing, mild facial swelling received IV Benadryl, IM epinephrine, IV methylprednisolone
Immediate headache and expected lethargy; Next day - fever and aches;  Nov. 23 - Sore chest - as if it were bruised;  racing erratic pulse - felt like my heart would fly out of my chest; pounding, especially at night time.  These symptoms  lasted until Dec 3-4, then gradually subsided.
Pt received Moderna #1 on 02/18/2021.  Lot #016M20A. Exp. 05/02/2021 mother signed consent. Pt placed on the schedule for dose #1.  No symptoms noted.
Information has been received from a physician concerning a patient who was vaccinated with oral 2ml Rotateq. Subsequently, the patient experienced patient received a second dose of rotateq early. Additional information has been requested.
12 hours later; massive diarrhea, vomiting, gastro bloating/pain - lasted for 18 hours
temp in excess 104 R; crying off & on since 8PM; exceedingly somnolent this AM to MD for neuro exam this AM;
It got progressively worse & got hives; Both arms started itching, mostly the left at first; Lethargy; Soreness in left arm; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (It got progressively worse & got hives), PRURITUS (Both arms started itching, mostly the left at first), LETHARGY (Lethargy), MYALGIA (Soreness in left arm), HEADACHE (Headache) and CHILLS (Chills) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced LETHARGY (Lethargy) (seriousness criterion medically significant), MYALGIA (Soreness in left arm) (seriousness criterion medically significant), HEADACHE (Headache) (seriousness criterion medically significant) and CHILLS (Chills) (seriousness criterion medically significant). On 02-Apr-2021, the patient experienced URTICARIA (It got progressively worse & got hives) (seriousness criterion medically significant) and PRURITUS (Both arms started itching, mostly the left at first) (seriousness criterion medically significant). The patient was treated with PREDNISONE on 05-Apr-2021 at a dose of 20 milligram and PREDNISONE on 14-Apr-2021 at a dose of 10 milligram. At the time of the report, URTICARIA (It got progressively worse & got hives), PRURITUS (Both arms started itching, mostly the left at first), LETHARGY (Lethargy), MYALGIA (Soreness in left arm), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by reporter.  On 05 Apr 2021, the patient went to the Emergency Room and was prescribed Prednisone 20 mg 2 tabs daily for four days. The hives went away after the 4th day but came right back.  On 14 Apr 2021, the patient went to the dermatologist. At that time the hives continued and were spread on quads, calves, hands and back. The dermatologist prescribed Prednisone 10mg with titrating dose over two weeks.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-254133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Non significant follow up appended; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Swelling arm; Sharp pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling arm) and PAIN (Sharp pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling arm) and PAIN (Sharp pain). At the time of the report, PERIPHERAL SWELLING (Swelling arm) and PAIN (Sharp pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No concomitant medications were reported. No treatment related information has been reported.   Reporter did not allow further contact
focal sz 1MAY94 some question that parents may have witnessed a focal sz the wk or 2 prior to event;
High resting HR, fatigue (extreme), UTI, low grade fever.  To date it's been 16 days and still high resting HR (20 bpm above normal), fatigue.  Antibiotics helped UTI.
Shortness of breath; heartbeat up a little bit; Nausea: Caller stated this started on the afternoon day she took the second dose of the vaccine.; Drowsiness dizziness; Headache; dizziness; Chills: Caller stated this started with the first dose of the vaccine and also with the second dose.; Sweating; could not move arm; pain at location; caller received the vaccine less than 3 weeks apart; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), dose 2 intramuscular, administered in Arm Left on 19Apr2021 at 07:30 (age at vaccination 44-years-old) as dose 2, single for covid-19 immunization. The patient's medical history included fibromyalgia from an unknown. The patient's concomitant medications were not reported. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number was not reported, Expiry date was not reported), via an unspecified route of administration, administered in left arm on muscle on 05Apr2021 as dose 1, single for COVID-19 immunization which reported the events like Chills, Sweating, Pain at location, Could not move arm, Drowsiness dizziness, Headache and fatigue. In 2021, the patient received the vaccine less than 3 weeks apart. On Apr2021, had chills: patient stated that started with the first dose of the vaccine and with the second dose, had sweating and could not move arm, pain at location. On 19Apr2021, nausea: patient stated this started on the afternoon day he took the second dose of the vaccine, had drowsiness, dizziness, headache, heartbeat up a little bit. On 20Apr2021, the patient had shortness of breath. The Caller stated she has never had a doctor. She usually goes to her yearly gynecologist but her gynecologist was closing her practice and she was not working anymore. Caller stated she does not go to unwell review to see a healthcare doctor. The outcome of caller received the vaccine less than 3 weeks apart was unknown, Outcome of Chills: Caller stated this started with the first dose of the vaccine and with the second dose, Nausea: Caller stated this started on the afternoon day she took the second dose of the vaccine, Sweating and could not move arm were recovered on 21Apr2021. The outcome of heartbeat up a little bit was recovered on the same day. The outcome of Drowsiness dizziness, Headache, dizziness and pain at location was recovering, the outcome of Shortness of breath was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling, redness, tenderness 4 cm x 10 cm. Inferior to injection site. Afebrile. Treatment Benadryl & Augmentin Sorgupizion for cellulitis.
Information has been received from a registered nurse concerning a patient who on 13-JUL-2007 was vaccinated with the first dose of Rotateq. On 13-JUL-2007 the patient developed vomiting during administration and the patient only received some of the dose. It is unknown if medical attention was sought. The patient's present status is unknown at this time. No product quality complaint was reported. Additional information has been requested.